![Matthew Ronsheim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Ronsheim
Directeur des opérations chez
XENON PHARMACEUTICALS INC.
Profil
Matthew D.
Ronsheim is Chief Operating Officer at Xenon Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Ronsheim was Executive Director & Head-Chemistry Manufacturing at Enanta Pharmaceuticals, Inc. from 2016 to 2019 and Chief Pharmaceutical Sciences Officer at Entasis Therapeutics Holdings, Inc. Education includes undergraduate studies at Southern Connecticut State University and a doctorate from the University of New Hampshire.
Postes actifs de Matthew Ronsheim
| Sociétés | Poste | Début |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Directeur des opérations | 12/08/2024 |
Anciens postes connus de Matthew Ronsheim
| Sociétés | Poste | Fin |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/08/2019 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Corporate Officer/Principal | - |
Formation de Matthew Ronsheim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Southern Connecticut State University
 Southern Connecticut State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
